 |
3 Diseases |  |
0 Trials |
|
0 Trials |  |
7 News |  |
- | AMG 747 / Amgen
Trial termination: 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) (clinicaltrials.gov) - Jun 13, 2013
P2, N=111, Terminated, Sponsor: Amgen
Recruiting --> Terminated; Toxic Epidermal Necrolysis
- | AMG 747 / Amgen
Trial termination: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (clinicaltrials.gov) - Jun 13, 2013
P2, N=121, Terminated, Sponsor: Amgen
Recruiting --> Terminated; Toxic Epidermal Necrolysis Recruiting --> Terminated; Toxic Epidermal Necrolysis
- AMG 747 / Amgen
Enrollment change: 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) (clinicaltrials.gov) - Jun 13, 2013
P2, N=111, Terminated, Sponsor: Amgen
Recruiting --> Terminated; Toxic Epidermal Necrolysis N=270 --> 111
- AMG 747 / Amgen
Enrollment change: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (clinicaltrials.gov) - Jun 13, 2013
P2, N=121, Terminated, Sponsor: Amgen
N=270 --> 111 N=270 --> 121
- | AMG 747 / Amgen
New P2 trial: 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) (clinicaltrials.gov) - Mar 29, 2012
P2, N=111, Terminated, Sponsor: Amgen
- | AMG 747 / Amgen
New P2 trial: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (clinicaltrials.gov) - Mar 29, 2012
P2, N=121, Terminated, Sponsor: Amgen